Stock listing
Dx & Vx Co., Ltd.
Selected listing: 180400 · KRX · KRW · KR
Dx & Vx Co., Ltd. (KRX:180400), Health Technology. Latest release Sep 26, 2025: COREE Announces Discovery of Microbiome Biomarkers Specific to Diabetes…
- Ticker
- KRX:180400
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- KRX
- Currency
- KRW
About Dx & Vx Co., Ltd.
Dx & Vx Co., Ltd. is a public company listed on the Korea Stock Exchange under the ticker 180400. It operates in the biotechnology sector, focusing on the development and commercialization of innovative solutions.
Latest news from Dx & Vx Co., Ltd.
COREE Announces Discovery of Microbiome Biomarkers Specific to Diabetes and Obesity Patients
September 26, 2025
Avixgen, a subsidiary of Dx&Vx, signs a licensing-out agreement worth USD 360 million with a U.S. biotech company for its next-generation drug delivery platform (ACP).
August 18, 2025
Dx&Vx Signs USD 220 Million Co-Development and License Agreement for mRNA Cancer Vaccine with U.S. Biotech Company
July 30, 2025
Dx&Vx Accelerates Development of Universal COVID-19 Vaccine
May 29, 2025